American Journal of Kidney Diseases

Effect of Hemodiafiltration or Hemofiltration Compared With Hemodialysis on Mortality and Cardiovascular Disease in Chronic Kidney Failure: A Systematic Review and Meta-analysis of Randomized Trials

Published:March 31, 2014DOI:


      Whether convective modalities of dialysis, including hemofiltration (HF) and hemodiafiltration (HDF), improve cardiovascular outcomes and mortality is unclear.

      Study Design

      Systematic review and meta-analysis.

      Setting & Population

      Patients receiving HDF, HF, or standard hemodialysis (HD).

      Selection Criteria for Studies

      Randomized controlled trials.


      Convective modalities of dialysis (HDF and HF) versus standard HD.


      The primary outcome was clinical cardiovascular outcomes. Secondary outcomes were all-cause mortality, episodes of symptomatic hypotension, dialysis adequacy, and β2-microglobulin level. Relative risks (RRs) or weighted mean differences with 95% CIs for individual trials were pooled using random-effects models.


      The search yielded 16 trials including 3,220 patients. Therapies assessed were convective modalities (HDF or HF) compared with standard HD. Compared with HD, convective modalities did not significantly reduce the risk of cardiovascular events (RR, 0.85; 95% CI, 0.66-1.10) or all-cause mortality (RR, 0.83; 95% CI, 0.65-1.05). Convective modalities reduced symptomatic hypotension (RR, 0.49; 95% CI, 0.30-0.81) and improved serum β2-microglobulin levels (−5.95 mg/L; 95% CI, −10.27 to −1.64), but had no impact on small-molecule clearance (weighted mean difference in Kt/V, 0.04; 95% CI, −0.04 to 0.12). There was a nonsignificant trend to a greater likelihood of receiving a kidney transplant for participants allocated to filtration therapies (RR, 1.19; 95% CI, 0.99-1.42).


      The trials were predominantly of suboptimal quality and underpowered, with imbalance in some prognostic variables at baseline. Intention-to-treat analysis was not used in some trials. Our analysis was limited to published outcomes.


      The potential benefits of convective modalities over standard HD for cardiovascular outcomes and mortality remain unproved. Further high-quality randomized trials are needed to define the impact of these modalities on clinically important outcomes.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Tonelli M.
        • Wiebe N.
        • Culleton B.
        • et al.
        Chronic kidney disease and mortality risk: a systematic review.
        J Am Soc Nephrol. 2006; 17: 2034-2047
        • Schiffrin E.L.
        • Lipman M.L.
        • Mann J.F.
        Chronic kidney disease: effects on the cardiovascular system.
        Circulation. 2007; 116: 85-97
        • Go A.S.
        • Chertow G.M.
        • Fan D.
        • McCulloch C.E.
        • Hsu C.Y.
        Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
        N Engl J Med. 2004; 351: 1296-1305
        • Winchester J.F.
        • Silberzweig J.
        • Ronco C.
        • et al.
        Sorbents in acute renal failure and end-stage renal disease: middle molecule and cytokine removal.
        Blood Purif. 2004; 22: 73-77
        • Altieri P.
        • Sorba G.
        • Bolasco P.
        • et al.
        Pre-dilution haemofiltration—the Sardinian multicentre studies: present and future. The Sardinian Collaborative Study Group on Haemofiltration On-Line.
        Nephrol Dial Transplant. 2000; 15: 55-59
        • Collins A.J.
        • Keshaviah P.
        • Ilstrup K.M.
        • Shapiro F.
        Clinical comparison of hemodialysis and hemofiltration.
        Kidney Int Suppl. 1985; 17: S18-S22
        • Canaud B.
        • Bosc J.Y.
        • Leray-Moragues H.
        • et al.
        On-line haemodiafiltration. Safety and efficacy in long-term clinical practice.
        Nephrol Dial Transplant. 2000; 15: 60-67
        • Locatelli F.
        • Marcelli D.
        • Conte F.
        • Limido A.
        • Malberti F.
        • Spotti D.
        Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto.
        Kidney Int. 1999; 55: 286-293
        • Lowrie E.G.
        • Teehan B.P.
        Principles of prescribing dialysis therapy: implementing recommendations from the National Cooperative Dialysis Study.
        Kidney Int Suppl. 1983; 13: S113-S122
        • Locatelli F.
        • Del Vecchio L.
        • Manzoni C.
        Morbidity and mortality on maintenance haemodialysis.
        Nephron. 1998; 80: 380-400
        • Henderson L.W.
        Hemofiltration for the treatment of hypertensions associated with end-stage renal failure.
        Artif Organs. 1980; 4: 103-107
        • Ledebo I.
        Principles and practice of hemofiltration and hemodiafiltration.
        Artif Organs. 1998; 22: 20-25
        • Wizemann V.
        • Kulz M.
        • Techert F.
        • Nederlof B.
        Efficacy of haemodiafiltration.
        Nephrol Dial Transplant. 2001; 16: 27-30
        • Li X.
        • Li M.
        • Liu T.
        • et al.
        Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness.
        Chin Med J. 1997; 110: 520-525
        • Maduell F.
        • Moreso F.
        • Pons M.
        • et al.
        High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.
        J Am Soc Nephrol. 2013; 24: 487-497
        • Canaud B.
        • Morena M.
        • Leray-Moragues H.
        • Chalabi L.
        • Cristol J.P.
        Overview of clinical studies in hemodiafiltration: what do we need now ?.
        Hemodial Int. 2006; 10: S5-S12
        • Liberati A.
        • Altman D.G.
        • Tetzlaff J.
        • et al.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
        J Clin Epidemiol. 2009; 62: e1-e34
      1. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. Accessed July 8, 2013.

        • Hartung J.
        • Knapp G.
        A refined method for the meta-analysis of controlled clinical trials with binary outcome.
        Stat Med. 2001; 20: 3875-3889
        • Locatelli F.
        • Mastrangelo F.
        • Redaelli B.
        • et al.
        Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group.
        Kidney Int. 1996; 50: 1293-1302
        • Verzetti G.
        • Navino C.
        • Bolzani R.
        • Galli G.
        • Panzetta G.
        Acetate-free biofiltration versus bicarbonate haemodialysis in the treatment of patients with diabetic nephropathy: a cross-over multicentric study.
        Nephrol Dial Transplant. 1998; 13: 955-961
        • Schrander-vd Meer A.M.
        • ter Wee P.M.
        • Donker A.J.
        • van Dorp W.T.
        Dialysis efficacy during acetate-free biofiltration.
        Nephrol Dial Transplant. 1998; 13: 370-374
        • Ward R.A.
        • Schmidt B.
        • Hullin J.
        • Hillebrand G.F.
        • Samtleben W.
        A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study.
        J Am Soc Nephrol. 2000; 11: 2344-2350
        • Eiselt J.
        • Racek J.
        • Opatrny Jr., K.
        The effect of hemodialysis and acetate-free biofiltration on anemia.
        Int J Artif Organs. 2000; 23: 173-180
        • Lin C.L.
        • Huang C.C.
        • Chang C.T.
        • et al.
        Clinical improvement by increased frequency of on-line hemodialfiltration.
        Ren Fail. 2001; 23: 193-206
        • Tuccillo S.
        • Bellizzi V.
        • Catapano F.
        • et al.
        Effetti acuti e cronici della emodialisi standard e dell'emodiafiltrazione-soft sui livelli interdialitici della fosforemia. [Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels].
        G Ital Nefrol. 2002; 19: 439-445
        • Beerenhout C.H.
        • Luik A.J.
        • Jeuken-Mertens S.G.
        • et al.
        Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study.
        Nephrol Dial Transplant. 2005; 20: 1155-1163
        • Schiffl H.
        Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
        Eur J Med Res. 2007; 12: 26-33
        • Santoro A.
        • Mancini E.
        • Bolzani R.
        • et al.
        The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
        Am J Kidney Dis. 2008; 52: 507-518
        • Locatelli F.
        • Altieri P.
        • Andrulli S.
        • et al.
        Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD.
        J Am Soc Nephrol. 2010; 21: 1798-1807
        • Alvestrand A.
        • Ledebo I.
        • Hagerman I.
        • et al.
        Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study.
        Blood Purif. 2011; 32: 21-29
        • Grooteman M.P.
        • van den Dorpel M.A.
        • Bots M.L.
        • et al.
        Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes.
        J Am Soc Nephrol. 2012; 23: 1087-1096
        • Ok E.
        • Asci G.
        • Toz H.
        • et al.
        Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study.
        Nephrol Dial Transplant. 2013; 28: 192-202
        • Moreiras-Plaza M.
        • Blanco-Garcia R.
        • Cossio-Aranibar C.R.
        • Rodriguez-Goyanes G.
        Assessment of health-related quality of life: the cinderella of peritoneal dialysis?.
        Int J Nephrol. 2011; 2011: 528685
        • Mazairac A.H.
        • de Wit G.A.
        • Grooteman M.P.
        • et al.
        Effect of hemodiafiltration on quality of life over time.
        Clin J Am Soc Nephrol. 2013; 8: 82-89
        • Rabindranath K.S.
        • Strippoli G.F.
        • Daly C.
        • Roderick P.J.
        • Wallace S.
        • MacLeod A.M.
        Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
        Cochrane Database Syst Rev. 2006; 4: CD006258
      2. Canaud B, Morena M, Jausson I, Cristol JP. Clinical tolerance of online HDF and impact on morbidity and cardiovascular risk factors in ESRD patients of 65 and more years old. Project supported by a French National Grant from Health Ministry (PHRC national). 2004.

        • Canaud B.
        • Flavier J.L.
        • Argiles A.
        • et al.
        Hemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy.
        Contrib Nephrol. 1994; 108: 12-22
        • Del Vecchio M.
        • Giordana G.
        • Pedrini L.
        • Marcelli D.
        • Sisti N.
        Elements for economic evaluation on online hemodiafiltration (ol-HDF) versus standard haemodialysis to treat patients with end-stage renal disease (ESRD).
        Ital J Public Health. 2012; 9: S1-S48
        • Petrie J.J.
        • Ng T.G.
        • Hawley C.M.
        Review article: is it time to embrace haemodiafiltration for centre-based haemodialysis?.
        Nephrology. 2008; 13: 269-277